Angelika Vlachou
Private Equity Investor chez High-Tech Gründerfonds Management GmbH
Profil
Dr. Angelika Vlachou has been investing venture capital in biotech, pharma and life science start-ups for over 10 years.
Over the course of her career, she has managed many transactions ranging from seed-stage venture capital and growth financing to licensing agreements, trade sale transactions and IPOs.
Her expertise is also based on her virology-molecular biology research experience.
One of her strengths is to combine scientific innovation with commercial potential.
She is a valued sparring partner for founders, investors and stakeholders.
With a doctorate in biology, she started her professional career in investment banking.
Postes actifs de Angelika Vlachou
Sociétés | Poste | Début |
---|---|---|
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Private Equity Investor | 01/01/2021 |
Anciens postes connus de Angelika Vlachou
Sociétés | Poste | Fin |
---|---|---|
Caterna Vision GmbH
Caterna Vision GmbH Medical/Nursing ServicesHealth Services Caterna Vision GmbH provides and develops technologies for the vision therapy. It develops and markets treatment software for therapeutic applications in ophthalmology. The firm’s product is used in the treatment of amblyopia. The company founded by Nicolaus Widera and Sascha Seewald in 2013 and is headquartered in Berlin, Germany. | Directeur/Membre du Conseil | 31/07/2021 |
4TEEN4 Pharmaceuticals GmbH
4TEEN4 Pharmaceuticals GmbH BiotechnologyHealth Technology 4teen4 Pharmaceuticals GmbH engages in the research and development in diagnostic and therapeutics bio markets. The company was founded by Andreas Bergmann in 2013 and is headquartered in Hennigsdorf, Germany. | Directeur/Membre du Conseil | 31/07/2021 |
Brandenburg Kapital GmbH | Private Equity Investor | 31/07/2021 |
Emperra GmbH E-Health Technologies
Emperra GmbH E-Health Technologies Medical SpecialtiesHealth Technology Emperra GmbH E-Health Technologies manufactures and designs telemedicine technologies. The firm specializes in the development of medical monitoring devices for the tracking and transmission of diabetic patients' diagnostic and therapeutic data. It develops components and systems under the ESYSTA product brand, featuring data acquisition, analysis, and transfer solutions. The company was founded by Janko Schildt in 2008 and is headquartered in Potsdam, Germany. | Directeur/Membre du Conseil | 31/07/2021 |
bmp Ventures /Venture Capital/
bmp Ventures /Venture Capital/ Investment ManagersFinance bmp Ventures /Venture Capital/ (bmp Ventures) is the venture capital arm of bmp Ventures AG. It was founded by Oliver Borrmann in 1997. The firm is headquartered in Berlin, Germany, with another German office located in Magdeburg. | Private Equity Investor | 31/03/2019 |
Formation de Angelika Vlachou
University of Giessen | Doctorate Degree |
University of Potsdam | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 9 |
---|---|
Concord Investmentbank AG (Broker) | Finance |
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH
IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH Investment ManagersFinance Beteiligungsgesellschaft Sachsen-Anhalt mbH is a private equity/ venture capital firm founded in 1996. The firm is headquartered in Magedeburg. | Finance |
bmp Ventures /Venture Capital/
bmp Ventures /Venture Capital/ Investment ManagersFinance bmp Ventures /Venture Capital/ (bmp Ventures) is the venture capital arm of bmp Ventures AG. It was founded by Oliver Borrmann in 1997. The firm is headquartered in Berlin, Germany, with another German office located in Magdeburg. | Finance |
High-Tech Gründerfonds Management GmbH
High-Tech Gründerfonds Management GmbH Investment ManagersFinance High-Tech Gründerfonds Management GmbH (HTGF) is a venture capital firm founded in 2005. The firm is headquartered in Bonn, Germany. | Finance |
Caterna Vision GmbH
Caterna Vision GmbH Medical/Nursing ServicesHealth Services Caterna Vision GmbH provides and develops technologies for the vision therapy. It develops and markets treatment software for therapeutic applications in ophthalmology. The firm’s product is used in the treatment of amblyopia. The company founded by Nicolaus Widera and Sascha Seewald in 2013 and is headquartered in Berlin, Germany. | Health Services |
4TEEN4 Pharmaceuticals GmbH
4TEEN4 Pharmaceuticals GmbH BiotechnologyHealth Technology 4teen4 Pharmaceuticals GmbH engages in the research and development in diagnostic and therapeutics bio markets. The company was founded by Andreas Bergmann in 2013 and is headquartered in Hennigsdorf, Germany. | Health Technology |
Brandenburg Kapital GmbH | Finance |
Emperra GmbH E-Health Technologies
Emperra GmbH E-Health Technologies Medical SpecialtiesHealth Technology Emperra GmbH E-Health Technologies manufactures and designs telemedicine technologies. The firm specializes in the development of medical monitoring devices for the tracking and transmission of diabetic patients' diagnostic and therapeutic data. It develops components and systems under the ESYSTA product brand, featuring data acquisition, analysis, and transfer solutions. The company was founded by Janko Schildt in 2008 and is headquartered in Potsdam, Germany. | Health Technology |
GoodVent Beteiligungsmanagement GmbH & Co. KG
GoodVent Beteiligungsmanagement GmbH & Co. KG Investment ManagersFinance GoodVent Beteiligungsmanagement GmbH & Co. KG is a private equity firm located in Magdeburg in the central-eastern part of Germany. The firm originated in 2000 to take over the business of the pre-existing investment arm of Land Sachsen-Anhalt. Previously known as IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the firm was privatized in 2007, and was briefly renamed Acceres Beteiligungsmanagement GmbH & Co. KG. GoodVent manages the IBG venture capital funds. | Finance |